DK1383489T3 - Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af neurodegeneative sygdomme - Google Patents

Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af neurodegeneative sygdomme

Info

Publication number: DK1383489T3
Authority: DK; Denmark
Prior art keywords: prevention; treatment; neurodegenerative diseases; carbamate compounds; carbamate
Prior art date: 2001-02-27

Application number

DK02714977T

Other languages

Danish (da)

English (en)

Inventor

Boyu Zhao

Carlos R Plata-Salaman

Roy E Twyman

Original Assignee

Ortho Mcneil Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-27

Filing date

2002-02-21

Publication date

2007-08-06

2002-02-21 Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc

2007-08-06 Application granted granted Critical

2007-08-06 Publication of DK1383489T3 publication Critical patent/DK1383489T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Psychology (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK02714977T 2001-02-27 2002-02-21 Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af neurodegeneative sygdomme DK1383489T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US27168201P	2001-02-27	2001-02-27
PCT/US2002/005541 WO2002067925A1 (fr)	2001-02-27	2002-02-21	Composes a base de carbamate destines a etre utilises dans la prevention ou le traitement de troubles neurodegeneratifs
US10/081,764 US20020165273A1 (en)	2001-02-27	2002-02-21	Carbamate compounds for use in preventing or treating neurodegenerative disorders

Publications (1)

Publication Number	Publication Date
DK1383489T3 true DK1383489T3 (da)	2007-08-06

Family

ID=26765943

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02714977T DK1383489T3 (da)	2001-02-27	2002-02-21	Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af neurodegeneative sygdomme

Country Status (26)

Country	Link
US (3)	US20020165273A1 (fr)
EP (1)	EP1383489B1 (fr)
JP (1)	JP4276840B2 (fr)
KR (1)	KR100910928B1 (fr)
CN (1)	CN1235579C (fr)
AR (1)	AR035756A1 (fr)
AT (1)	ATE361745T1 (fr)
BR (1)	BR0207645A (fr)
CA (1)	CA2439295C (fr)
CY (1)	CY1106753T1 (fr)
CZ (1)	CZ301203B6 (fr)
DE (1)	DE60220043T2 (fr)
DK (1)	DK1383489T3 (fr)
ES (1)	ES2284845T3 (fr)
HU (1)	HUP0303264A3 (fr)
IL (2)	IL157591A0 (fr)
MX (1)	MXPA03007718A (fr)
MY (1)	MY138156A (fr)
NO (1)	NO20033798L (fr)
NZ (1)	NZ527990A (fr)
PL (1)	PL364680A1 (fr)
PT (1)	PT1383489E (fr)
RS (1)	RS51055B (fr)
RU (1)	RU2300373C2 (fr)
TW (1)	TWI312679B (fr)
WO (1)	WO2002067925A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7470798B2 (en) *	2003-09-19	2008-12-30	Edison Pharmaceuticals, Inc.	7,8-bicycloalkyl-chroman derivatives
CN101056629B (zh) *	2004-09-16	2012-01-11	詹森药业有限公司	2-苯基-1,2-乙二醇-(二)氨基甲酸酯在制备治疗癫痫发生的药物中的用途
JP2008516961A (ja) *	2004-10-15	2008-05-22	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	神経変性障害を処置することにおける使用のためのカルバメート化合物
US20070021500A1 (en) *	2005-07-12	2007-01-25	Twyman Roy E	Methods for neuroprotection
CN101272776B (zh) *	2005-07-26	2012-10-03	詹森药业有限公司	氨基甲酸酯在制备治疗物质滥用相关疾病药物中的用途
KR20090076958A (ko) *	2006-10-06	2009-07-13	얀센 파마슈티카 엔.브이.	신규 (ｓ)-(＋)-2-(2-클로로페닐)-2-하이드록시-에틸 카바메이트 결정
US20080317883A1 (en) *	2006-10-30	2008-12-25	Yong Moon Choi	Methods for treating depression
MX2009004798A (es) *	2006-10-31	2009-08-12	Janssen Pharmaceutica Nv	Tratamiento de los trastornos generalizados del desarrollo.
US9018253B2 (en)	2010-07-02	2015-04-28	Bio-Pharm Solutions Co., Ltd.	Phenylcarbamate compound and muscle relaxant containing the same
JP5774694B2 (ja) *	2010-07-02	2015-09-09	バイオ−ファームソリューションズカンパニーリミテッド	フェニルカルバメート化合物およびこれを含む筋肉弛緩剤
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
WO2013036678A1 (fr) *	2011-09-07	2013-03-14	Satori Pharmaceuticals, Inc.	Composés utiles pour le traitement de maladies neurodégénératives
EP2797881B1 (fr)	2011-12-27	2018-11-14	Bio-Pharm Solutions Co., Ltd.	Composé de dérivés de carbamate d'alkyle phényle et composition pharmaceutique le contenant
JP6062077B2 (ja)	2013-03-12	2017-01-18	バイオ−ファームソリューションズカンパニーリミテッド	小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物｛ｐｈｅｎｙｌｃａｒｂａｍａｔｅｃｏｍｐｏｕｎｄｓｆｏｒｕｓｅｉｎｐｒｅｖｅｎｔｉｎｇｏｒｔｒｅａｔｉｎｇｐｅｄｉａｔｒｉｃｅｐｉｌｅｓｙａｎｄｅｐｉｌｅｓｙ−ｒｅｌａｔｅｄｓｙｎｄｒｏｍｅｓ｝
CN105164103B (zh) *	2013-03-12	2019-12-06	比皮艾思药物研发有限公司	苯基氨基甲酸酯化合物和含有其的预防或治疗记忆缺失相关疾病的组合物
KR102121680B1 (ko) *	2016-02-29	2020-06-10	(주)바이오팜솔루션즈	설파메이트 유도체 화합물, 이의 제조 방법 및 용도
US11147798B2 (en)	2016-12-14	2021-10-19	Sk Biopharmaceuticals Co., Ltd.	Use of carbamate compound for prevention, alleviation, or treatment of demyelinating disease
US20220117941A1 (en) *	2018-09-21	2022-04-21	Sk Biopharmaceuticals Co., Ltd.	Carbamate compound and use of formulation comprising same in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder
BR112023003473A2 (pt) *	2020-08-31	2023-04-11	Bio Pharm Solutions Co Ltd	Compostos de carbamato de alquil fenila para o uso na prevenção ou no tratamento de doença neurodegenerativa
BR112023004354A2 (pt)	2020-09-10	2023-04-04	Bio Pharm Solutions Co Ltd	Compostos derivados de sulfamato para uso no tratamento ou alívio de um transtorno psiquiátrico

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3313692A (en) *	1958-04-21	1967-04-11	Armour Pharma	Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) *	1962-02-06	1966-10-11	Armour Pharma	Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) *	1962-07-18	1966-08-09	Armour Pharma	Substituted phenethyl carbamates
US5474990A (en) *	1989-10-20	1995-12-12	Olney; John W.	Barbiturates as safening agents in conjunction with NMDA antagonists
CN1109880A (zh) *	1994-02-03	1995-10-11	合成实验室公司	3-(2-氨基乙基)-4-[3-(三氟甲基)苯甲酰基]-3，4-二氢-2h-1，4-苯并噁嗪衍生物、制备及其应用
US5492930A (en) *	1994-04-25	1996-02-20	Schering Corporation	Method and formulation for treating CNS disorders
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US5728728A (en) *	1996-04-10	1998-03-17	Kozachuk; Walter E.	Methods of providing neuroprotection
US6232434B1 (en) *	1996-08-02	2001-05-15	Duke University Medical Center	Polymers for delivering nitric oxide in vivo
KR100886578B1 (ko) *	2001-02-27	2009-03-05	오르토-맥네일 파마슈티칼, 인코퍼레이티드	카바메이트 화합물을 포함하는 정신증 장애 예방용 또는 치료용 약제학적 조성물
ATE369130T1 (de) *	2001-02-27	2007-08-15	Ortho Mcneil Pharm Inc	Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen
CN1250215C (zh) *	2001-02-27	2006-04-12	奥索-麦克尼尔药品公司	用于预防或治疗双相性精神障碍的氨基甲酸酯化合物

2002
- 2002-02-21 PT PT02714977T patent/PT1383489E/pt unknown
- 2002-02-21 CZ CZ20032313A patent/CZ301203B6/cs not_active IP Right Cessation
- 2002-02-21 ES ES02714977T patent/ES2284845T3/es not_active Expired - Lifetime
- 2002-02-21 CN CNB028087178A patent/CN1235579C/zh not_active Expired - Fee Related
- 2002-02-21 CA CA2439295A patent/CA2439295C/fr not_active Expired - Fee Related
- 2002-02-21 US US10/081,764 patent/US20020165273A1/en not_active Abandoned
- 2002-02-21 HU HU0303264A patent/HUP0303264A3/hu unknown
- 2002-02-21 IL IL15759102A patent/IL157591A0/xx unknown
- 2002-02-21 JP JP2002567292A patent/JP4276840B2/ja not_active Expired - Fee Related
- 2002-02-21 EP EP02714977A patent/EP1383489B1/fr not_active Expired - Lifetime
- 2002-02-21 RS YUP-674/03A patent/RS51055B/sr unknown
- 2002-02-21 BR BR0207645-4A patent/BR0207645A/pt not_active Application Discontinuation
- 2002-02-21 KR KR1020037011302A patent/KR100910928B1/ko not_active Expired - Fee Related
- 2002-02-21 RU RU2003128982/14A patent/RU2300373C2/ru not_active IP Right Cessation
- 2002-02-21 AT AT02714977T patent/ATE361745T1/de active
- 2002-02-21 DE DE60220043T patent/DE60220043T2/de not_active Expired - Lifetime
- 2002-02-21 MX MXPA03007718A patent/MXPA03007718A/es active IP Right Grant
- 2002-02-21 NZ NZ527990A patent/NZ527990A/en unknown
- 2002-02-21 PL PL02364680A patent/PL364680A1/xx unknown
- 2002-02-21 DK DK02714977T patent/DK1383489T3/da active
- 2002-02-21 WO PCT/US2002/005541 patent/WO2002067925A1/fr not_active Ceased
- 2002-02-27 MY MYPI20020697A patent/MY138156A/en unknown
- 2002-02-27 AR ARP020100697A patent/AR035756A1/es unknown
- 2002-02-27 TW TW091103504A patent/TWI312679B/zh active
2003
- 2003-08-26 IL IL157591A patent/IL157591A/en not_active IP Right Cessation
- 2003-08-26 NO NO20033798A patent/NO20033798L/no not_active Application Discontinuation
2004
- 2004-03-10 US US10/797,795 patent/US20040171679A1/en not_active Abandoned
2007
- 2007-07-24 CY CY20071100982T patent/CY1106753T1/el unknown
2008
- 2008-09-10 US US12/207,816 patent/US20090005442A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HK1065486A1 (en)	2005-02-25
NO20033798D0 (no)	2003-08-26
RS51055B (sr)	2010-10-31
AR035756A1 (es)	2004-07-07
JP4276840B2 (ja)	2009-06-10
IL157591A (en)	2009-12-24
NZ527990A (en)	2006-01-27
CZ20032313A3 (cs)	2004-08-18
HK1060516A1 (en)	2004-08-13
NO20033798L (no)	2003-09-26
TWI312679B (en)	2009-08-01
MY138156A (en)	2009-04-30
US20020165273A1 (en)	2002-11-07
IL157591A0 (en)	2004-03-28
CA2439295A1 (fr)	2002-09-06
BR0207645A (pt)	2004-12-28
RS67403A (sr)	2006-12-15
RU2300373C2 (ru)	2007-06-10
PL364680A1 (en)	2004-12-13
ATE361745T1 (de)	2007-06-15
CY1106753T1 (el)	2012-05-23
ES2284845T3 (es)	2007-11-16
KR100910928B1 (ko)	2009-08-06
RU2003128982A (ru)	2005-03-10
HUP0303264A2 (hu)	2004-01-28
KR20030076714A (ko)	2003-09-26
CN1235579C (zh)	2006-01-11
WO2002067925A1 (fr)	2002-09-06
PT1383489E (pt)	2007-06-21
US20040171679A1 (en)	2004-09-02
EP1383489A1 (fr)	2004-01-28
EP1383489B1 (fr)	2007-05-09
DE60220043D1 (de)	2007-06-21
CZ301203B6 (cs)	2009-12-09
JP2004523555A (ja)	2004-08-05
US20090005442A1 (en)	2009-01-01
CN1503667A (zh)	2004-06-09
CA2439295C (fr)	2010-05-25
MXPA03007718A (es)	2004-11-12
DE60220043T2 (de)	2008-01-10
HUP0303264A3 (en)	2012-07-30

Publication	Publication Date	Title
DK1383489T3 (da)	2007-08-06	Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af neurodegeneative sygdomme
DK1427437T3 (da)	2013-03-04	Oxyntomodulin til forebyggelse eller behandling af overvægt
DK1446122T5 (da)	2006-08-14	Anvendelse af flibanserin til behandling af uregelmæssigheder ved könsdriften
DK1656372T3 (da)	2013-07-01	2,4-pyrimidindiaminforbindelser til anvendelse til behandling eller forebyggelse af autoimmunsygdomme
DK2412368T3 (da)	2013-11-04	Sammensætning til behandling af ar
DK1411917T3 (da)	2007-09-24	Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser
DK1478358T3 (da)	2013-10-07	Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese
DK1765388T3 (da)	2013-07-22	Kombinationsterapi til forebyggelse eller behandling af alzheimer's sygdom, og kit dertil
IS7099A (is)	2004-01-08	Efnasambönd til að meðhöndla bólgutruflanir
DK1663287T3 (da)	2009-11-09	Anvendelse af modificerede cyclosporiner til behandling af HCV-sygdomme
DK1448205T3 (da)	2011-12-12	Kombinationer til behandling af immunoinflammatoriske sygdomme
DK1259512T3 (da)	2003-12-29	Pteridinforbindelser til behandling af psoreasis
DK1411926T3 (da)	2005-08-29	Integrininhibitorer til behandling af öjensygdomme
DK1176964T3 (da)	2007-01-15	Brug af ET743 til behandling af cancer
IL175535A (en)	2016-03-31	Compositions for treatment of neurodegenerative diseases
DK1694342T3 (da)	2021-02-08	Fremgangsmåder til anvendelse af gelsolin til behandling eller forebyggelse af bakteriel sepsis
NO20035540D0 (no)	2003-12-11	Eksoterme preparater til behandling av ektoparasitter
DK1670482T4 (da)	2022-08-22	Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
NO20033804L (no)	2003-09-30	Karbamatforbindelser for behandling av smerte
DK1401424T3 (da)	2007-02-26	Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af psykotiske forstyrrelser
DK1344526T3 (da)	2008-09-15	Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser
DK1572613T3 (da)	2006-12-18	Fremgangsmåde til fremstilling af benzophenoner
DK1355668T3 (da)	2008-05-05	Anvendelse af IL-18 inhibitorer til behandling og/eller forebyggelsen af hjertesygdom
DK1268482T3 (da)	2003-12-22	Pyranoindoler til behandling af glaukom
DK1225890T3 (da)	2005-04-04	Rivastigmin til behandling af öjensygdomme